QUÉBEC CITY, Aug. 6, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") today announced that the Company's
Chairman, CEO, David Dodd, will be presenting a corporate overview at
the Canaccord Genuity 34th Annual Global Growth Conference on
Wednesday, August 13, 2014, at 1pm (Eastern), in the Melbourne Room of
the Intercontinental Hotel in Boston.
A live audio and slide webcast of the presentation will be available via
the Company's website at www.aezsinc.com in the "Newsroom" section, under "Events and Webcasts". A replay of the
webcast will also be available on the Company's website for a period of
90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company engaged in
developing and commercializing novel treatments in oncology and
endocrinology. The Company's pipeline encompasses compounds at various
stages of development. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com
Copyright CNW Group 2014